Related references
Note: Only part of the references are listed.Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Francesco Sardanelli et al.
EUROPEAN JOURNAL OF CANCER (2010)
Neoadjuvant Therapy for Breast Cancer
Stephen V. Liu et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and Without Bevacizumab
Shadfar Bahri et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Accuracy of Clinical Evaluation of Locally Advanced Breast Cancer in Patients Receiving Neoadjuvant Chemotherapy
Raquel Prati et al.
CANCER (2009)
Preoperative therapy in invasive breast cancer: Pathologic assessment and systemic therapy issues in operable disease
Julie R. Gralow et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference
Thomas A. Buchholz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
Francisco J. Esteva et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Vascular maps on contrast-enhanced breast MR images: A new approach requiring further investigation
Francesco Sardanelli
RADIOLOGY (2008)
Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps
A. C. Schmitz et al.
EUROPEAN RADIOLOGY (2008)
Targeting Microtubules to inhibit angiogenesis and disrupt tumour vasculature: Implications for cancer treatment
Eddy Pasquier et al.
CURRENT CANCER DRUG TARGETS (2007)
Monitoring therapeutic efficacy in breast carcinomas
Anne A. Tardivon et al.
EUROPEAN RADIOLOGY (2006)
Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer
Myron S. Kwong et al.
CANCER JOURNAL (2006)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: Association between invasive cancer and ipsilateral increased vascularity
F Sardanelli et al.
RADIOLOGY (2005)
Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer
F Montemurro et al.
EUROPEAN RADIOLOGY (2005)
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
G von Minckwitz et al.
ANNALS OF ONCOLOGY (2005)
Taxane-mediated antiangiogenesis in vitro:: Influence of formulation vehicles and binding proteins
SSW Ng et al.
CANCER RESEARCH (2004)
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
DS Grant et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Angiogenesis modulation in cancer research: Novel clinical approaches
M Cristofanilli et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
IC Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Docetaxel versus paclitaxel for antiangiogenesis
A Vacca et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Vascular morphogenesis and remodeling in a human tumor xenograft - Blood vessel formation and growth after ovariectomy and tumor implantation
S Patan et al.
CIRCULATION RESEARCH (2001)
Gadolinium-enhanced MR angiography of the breast: Is breast cancer associated with ipsilateral higher vascularity?
AE Mahfouz et al.
EUROPEAN RADIOLOGY (2001)
Share Paper
